Unknown

Dataset Information

0

Deletion of endothelial IGFBP5 protects against ischaemic hindlimb injury by promoting angiogenesis.


ABSTRACT:

Background

Angiogenesis is critical for forming new blood vessels from antedating vascular vessels. The endothelium is essential for angiogenesis, vascular remodelling and minimisation of functional deficits following ischaemia. The insulin-like growth factor (IGF) family is crucial for angiogenesis. Insulin-like growth factor-binding protein 5 (IGFBP5), a binding protein of the IGF family, may have places in angiogenesis, but the mechanisms are not yet completely understood. We sought to probe whether IGFBP5 is involved in pathological angiogenesis and uncover the molecular mechanisms behind it.

Methods and results

IGFBP5 expression was elevated in the vascular endothelium of gastrocnemius muscle from critical limb ischaemia patients and hindlimb ischaemic (HLI) mice and hypoxic human umbilical vein endothelial cells (HUVECs). In vivo, loss of endothelial IGFBP5 (IGFBP5EKO) facilitated the recovery of blood vessel function and limb necrosis in HLI mice. Moreover, skin damage healing and aortic ring sprouting were faster in IGFBP5EKO mice than in control mice. In vitro, the genetic inhibition of IGFBP5 in HUVECs significantly promoted tube formation, cell proliferation and migration by mediating the phosphorylation of IGF1R, Erk1/2 and Akt. Intriguingly, pharmacological treatment of HUVECs with recombinant human IGFBP5 ensued a contrasting effect on angiogenesis by inhibiting the IGF1 or IGF2 function. Genetic inhibition of IGFBP5 promoted cellular oxygen consumption and extracellular acidification rates via IGF1R-mediated glycolytic adenosine triphosphate (ATP) metabolism. Mechanistically, IGFBP5 exerted its role via E3 ubiquitin ligase Von Hippel-Lindau (VHL)-regulated HIF1α stability. Furthermore, the knockdown of the endothelial IGF1R partially abolished the reformative effect of IGFBP5EKO mice post-HLI.

Conclusion

Our findings demonstrate that IGFBP5 ablation enhances angiogenesis by promoting ATP metabolism and stabilising HIF1α, implying IGFBP5 is a novel therapeutic target for treating abnormal angiogenesis-related conditions.

SUBMITTER: Song F 

PROVIDER: S-EPMC11182737 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deletion of endothelial IGFBP5 protects against ischaemic hindlimb injury by promoting angiogenesis.

Song Fei F   Hu Yu Y   Hong Yi-Xiang YX   Sun Hu H   Han Yue Y   Mao Yi-Jie YJ   Wu Wei-Yin WY   Li Gang G   Wang Yan Y  

Clinical and translational medicine 20240601 6


<h4>Background</h4>Angiogenesis is critical for forming new blood vessels from antedating vascular vessels. The endothelium is essential for angiogenesis, vascular remodelling and minimisation of functional deficits following ischaemia. The insulin-like growth factor (IGF) family is crucial for angiogenesis. Insulin-like growth factor-binding protein 5 (IGFBP5), a binding protein of the IGF family, may have places in angiogenesis, but the mechanisms are not yet completely understood. We sought t  ...[more]

Similar Datasets

| S-EPMC107837 | biostudies-literature
| S-EPMC6562148 | biostudies-literature
| S-EPMC6975061 | biostudies-literature
| S-EPMC4726536 | biostudies-literature
| S-EPMC4120778 | biostudies-literature
| S-EPMC7550542 | biostudies-literature
| S-EPMC8034466 | biostudies-literature
2010-05-15 | E-GEOD-12426 | biostudies-arrayexpress
| S-EPMC9239578 | biostudies-literature
| S-EPMC5359186 | biostudies-literature